HERA

Jul 10 2025SCIENCE

A New Leader for Pulmonary Pharmacology & Therapeutics

Mario Cazzola has taken on a new role as an honorary editor for the journal Pulmonary Pharmacology & Therapeutics. This is a big deal because it means he gets to help shape the future of research in this field. But what does this really mean for the world of respiratory medicine? First, let's talk

reading time less than a minute
Jul 10 2025HEALTH

How DNA Testing Could Change How Doctors Treat a Blood Cancer

Chronic myeloid leukemia, or CML, is a blood cancer that's defined by a specific genetic change. Doctors have been using drugs that target this change, called tyrosine kinase inhibitors, to treat CML. These drugs have been a game-changer, but some patients don't respond well and their condition wors

reading time less than a minute
Jul 10 2025HEALTH

Cheaper or Better? Picking the Right Blood Thinner for Sick Patients

Doctors often use a machine to clean blood in very sick patients. This is called CRRT. Two common methods keep blood from clotting in the machine. One uses citrate. The other uses heparin. Both have pros and cons. But which one saves more money and works better? That's what experts wanted to find ou

reading time less than a minute
Jul 09 2025HEALTH

New Hope for Retinitis Pigmentosa: Targeting Cellular Messengers

Retinitis pigmentosa (RP) is a tricky condition. It's caused by faults in over 90 different genes. This makes it hard to treat because each case can be unique. Right now, gene therapies are limited and expensive. So, scientists are looking for a different approach. One that doesn't depend on the spe

reading time less than a minute
Jul 09 2025HEALTH

Exploring a New Hope for Rare Cancer Treatment

Chordoma is a tough cancer to treat. It's rare, and doctors don't have many options. But there's a new drug called palbociclib that might help. Researchers tested palbociclib on people with advanced chordoma. They wanted to see if it could stop the cancer from growing. The results are promising. P

reading time less than a minute
Jul 08 2025POLITICS

Wisconsin Takes a Stand Against Conversion Therapy

In a big move, Wisconsin's highest court just said the state can ban conversion therapy. This isn't just about one issue, though. It's also about who gets to make the rules in the state. The court said a group of lawmakers can't just block rules they don't like. This gives the governor more power to

reading time less than a minute
Jul 08 2025HEALTH

Can Kidney Tissue Clues Help Predict Treatment Success?

IgA nephropathy is a tricky kidney problem. Doctors have a tool called the Oxford Classification to guess how it might progress. This tool looks at kidney tissue and gives scores based on certain features. But does this tool also help predict how well patients will respond to steroid treatments? Tha

reading time less than a minute
Jul 08 2025HEALTH

Unveiling Real-World Insights: A Closer Look at Atopic Dermatitis Treatments

Atopic dermatitis, often called eczema, is a persistent skin issue that many people deal with. It causes inflammation and can be quite uncomfortable. While there are treatments available, there isn't much real-world data on how well they work, especially for those with moderate to severe cases. Ent

reading time less than a minute
Jul 07 2025HEALTH

How Long Should Treatment Last for Lung Cancer Surgery?

Lung cancer is a serious disease. Doctors often use a mix of treatments to fight it. One common approach is neoadjuvant chemoimmunotherapy. This treatment happens before surgery. It aims to shrink tumors and make them easier to remove. But how long should this treatment last? That's a big question.

reading time less than a minute
Jul 06 2025HEALTH

Smart Molecule Fights Cancer in Just Three Shots

Scientists have come up with a clever way to fight cancer using a special molecule. This molecule can find and attack cancer cells in the body. The tricky part about cancer is that it can hide from the body’s defense system. But this new treatment helps the body recognize and fight cancer cells. Th

reading time less than a minute